Skip to content
Research Article Open access CC BY 4.0

Detection of Androgen Receptor Gene Polymorphism in Sudanese Patients of Prostate Cancer in Khartoum State

Jumaa Abuajila Salem Salama, Dawelbiet Abdelaal Yahia, Mohamed Maysara Ali, Ahmed Elhadi Elsadig, Tarig A. M. Hamid

Journal of Cancer and Tumor International · pp. 26–29 · Published 1 Aug 2022

10.9734/jcti/2022/v12i430184

Abstract

Background: Prostate cancer (PCa) is the most commonly diagnosed solid tumor among men. Genetic susceptibility had been proposed among the risk factors for the development of this cancer. Aim: To investigate the effect of androgen receptor gene polymorphism in the susceptibility of prostate cancer among Sudanese patients. Methods: This study was conducted in Khartoum State during the period from December 2021 to May 2022. The study population that was selected consisted of one hundred patients, who had prostate cancer, who attended for routine follow-up assessment following their chemotherapy treatment. A total of 5 ml EDTA anti-coagulated venous blood samples were obtained from all participants. Prostate specific antigen (PSA) was measured by competitive chemiluminescence immunoassay. DNA extraction was performed for all samples by chemical method and genotyping was performed by PCR-RFLP method using Eco147I enzyme. Results: The Androgen receptor genotype showed that wild (G/G) type was more frequent (89%) than heterozygous (G/A) type (11%), and allele G was more frequent (94.5%)  than allele A (5.5%). The mean serum PSA level among prostate cancer patients was 18.71+31.68 ng/ml. Comparison of the mean serum PSA levels between different AR genotypes revealed no significant association between the genotype and the hormonal level (p. values > 0.05). Conclusion: Androgen receptor gene polymorphism was detected in this study population as heterozygous type. Moreover; there was no significant association between AR genotype and serum PSA level.

Androgen receptor (AR) prostate cancer (PCa) PSA-Sudan

References (7)

  1. 1 The nuclear receptor superfamily: The second decade [DOI]
  2. 2 MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS [DOI]
  3. 3 A Unified Nomenclature System for the Nuclear Receptor Superfamily [DOI]
  4. 4 Molecular Mechanisms of Action of Steroid/Thyroid Receptor Superfamily Members [DOI]
  5. 5 Epidemiology of Prostate Cancer in Africa: Another Step in the Understanding of the Disease? [DOI]
  6. 6 Prostate cancer and black men.
  7. 7 Predictive Risk Factors of Prostate Cancer Incidence in Khartoum State, Sudan [DOI]

Cited by 2

Identifying drug targets and evaluating KLK3-targeted inhibitors for prostate cancer using in-silico and in-vitro approaches

Imran Zafar, Shaista Shafiq, Adil Jamal · Medical Oncology · 2025

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

56

Page views

0

PDF downloads

9

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.